NCT00089245 2023-12-26Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerY-mAbs TherapeuticsPhase 1 Terminated177 enrolled
NCT02736565 2023-11-13Pbi-shRNAâ„¢ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's SarcomaGradalis, Inc.Phase 1 Completed7 enrolled
NCT03245151 2023-08-30Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System TumorsEisai Inc.Phase 1/2 Completed64 enrolled 29 charts
NCT00617890 2018-08-23A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)Merck Sharp & Dohme LLCPhase 2 Terminated219 enrolled 13 charts
NCT00668148 2018-07-17A Five-Tier, Open-Label Study of IMC-A12 in Advanced SarcomaEli Lilly and CompanyPhase 2 Completed113 enrolled 13 charts
NCT01585649 2016-05-18PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaTeva Branded Pharmaceutical Products R&D, Inc.Phase 1 Completed21 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00055952 2012-05-16Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell TumorDaiichi SankyoPhase 2 Completed